• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.60% Nasdaq Up 0.91%

    More On CANF

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    Ownership

    Financials

    Can-Fite BioPharma Ltd. (CANF)

    -NYSE MKT
    2.25 Down 0.06(2.77%) 12:10PM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:2.31
    Open:2.27
    Bid:2.24 x 2000
    Ask:2.25 x 500
    1y Target Est:3.15
    Beta:4.15
    Next Earnings Date:N/A
    Day's Range:2.22 - 2.27
    52wk Range:1.85 - 5.83
    Volume:119,815
    Avg Vol (3m):440,380
    Market Cap:23.94M
    P/E (ttm):N/A
    EPS (ttm):-0.70
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for CANF

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.28
    Quarterly EPS Est (Mar-15) :-0.07
    Mean Recommendation*:2.7
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Can-Fite BioPharma Ltd., a clinical-stage biopharmaceutical company, develops small molecule therapeutic products for the treatment of autoimmune-inflammatory, oncological, and ophthalmic diseases. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback